1. Home
  2. SERA vs HGBL Comparison

SERA vs HGBL Comparison

Compare SERA & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SERA
  • HGBL
  • Stock Information
  • Founded
  • SERA 2008
  • HGBL 1937
  • Country
  • SERA United States
  • HGBL United States
  • Employees
  • SERA N/A
  • HGBL N/A
  • Industry
  • SERA Precision Instruments
  • HGBL Business Services
  • Sector
  • SERA Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • SERA Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • SERA 87.4M
  • HGBL 75.5M
  • IPO Year
  • SERA 2021
  • HGBL N/A
  • Fundamental
  • Price
  • SERA $1.70
  • HGBL $2.15
  • Analyst Decision
  • SERA
  • HGBL Strong Buy
  • Analyst Count
  • SERA 0
  • HGBL 1
  • Target Price
  • SERA N/A
  • HGBL $4.00
  • AVG Volume (30 Days)
  • SERA 268.4K
  • HGBL 63.5K
  • Earning Date
  • SERA 05-07-2025
  • HGBL 05-08-2025
  • Dividend Yield
  • SERA N/A
  • HGBL N/A
  • EPS Growth
  • SERA N/A
  • HGBL N/A
  • EPS
  • SERA N/A
  • HGBL 0.12
  • Revenue
  • SERA $115,000.00
  • HGBL $46,659,000.00
  • Revenue This Year
  • SERA $390.13
  • HGBL $11.74
  • Revenue Next Year
  • SERA $440.54
  • HGBL $8.09
  • P/E Ratio
  • SERA N/A
  • HGBL $18.02
  • Revenue Growth
  • SERA N/A
  • HGBL N/A
  • 52 Week Low
  • SERA $1.53
  • HGBL $1.52
  • 52 Week High
  • SERA $9.37
  • HGBL $2.74
  • Technical
  • Relative Strength Index (RSI)
  • SERA 32.94
  • HGBL 53.54
  • Support Level
  • SERA $1.53
  • HGBL $2.10
  • Resistance Level
  • SERA $2.47
  • HGBL $2.25
  • Average True Range (ATR)
  • SERA 0.19
  • HGBL 0.08
  • MACD
  • SERA 0.02
  • HGBL -0.00
  • Stochastic Oscillator
  • SERA 18.18
  • HGBL 56.00

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: